Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2021-09-24 21:16:17 UTC
Update Date2021-09-24 21:16:18 UTC
HMDB IDHMDB0304897
Secondary Accession NumbersNone
Metabolite Identification
Common NameRevefenacin
DescriptionRevefenacin, also known as yupelri, belongs to the class of organic compounds known as n-benzylpiperidines. These are heterocyclic Compounds containing a piperidine ring conjugated to a benzyl group through one nitrogen ring atom. Based on a literature review very few articles have been published on Revefenacin.
Structure
Thumb
Synonyms
ValueSource
YupelriMeSH
Biphenyl-2-ylcarbamic acid 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl esterMeSH
1-({4-[(2-{4-[({[1,1'-biphenyl]-2-yl}-C-hydroxycarbonimidoyl)oxy]piperidin-1-yl}ethyl)(methyl)carbamoyl]phenyl}methyl)piperidine-4-carboximidateGenerator
Chemical FormulaC35H43N5O4
Average Molecular Weight597.76
Monoisotopic Molecular Weight597.331504885
IUPAC Name1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate
Traditional Name1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate
CAS Registry NumberNot Available
SMILES
CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
InChI Identifier
InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43)
InChI KeyFYDWDCIFZSGNBU-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as n-benzylpiperidines. These are heterocyclic Compounds containing a piperidine ring conjugated to a benzyl group through one nitrogen ring atom.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPiperidines
Sub ClassBenzylpiperidines
Direct ParentN-benzylpiperidines
Alternative Parents
Substituents
  • N-benzylpiperidine
  • Biphenyl
  • Phenylcarbamic acid ester
  • Benzamide
  • Benzoic acid or derivatives
  • Piperidinecarboxamide
  • Benzoyl
  • Benzylamine
  • Phenylmethylamine
  • Aralkylamine
  • Benzenoid
  • Monocyclic benzene moiety
  • Tertiary carboxylic acid amide
  • Carbamic acid ester
  • Tertiary aliphatic amine
  • Tertiary amine
  • Primary carboxylic acid amide
  • Carboxamide group
  • Amino acid or derivatives
  • Azacycle
  • Carboxylic acid derivative
  • Organooxygen compound
  • Organic oxide
  • Carbonyl group
  • Amine
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Organonitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
DispositionNot Available
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.24ALOGPS
logP3.81ChemAxon
logS-4.9ALOGPS
pKa (Strongest Acidic)12.74ChemAxon
pKa (Strongest Basic)8.65ChemAxon
Physiological Charge2ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area108.21 ŲChemAxon
Rotatable Bond Count11ChemAxon
Refractivity174.84 m³·mol⁻¹ChemAxon
Polarizability66.92 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+240.77532859911
AllCCS[M+H-H2O]+239.85832859911
AllCCS[M+Na]+241.81432859911
AllCCS[M+NH4]+241.58832859911
AllCCS[M-H]-220.29832859911
AllCCS[M+Na-2H]-223.30332859911
AllCCS[M+HCOO]-226.72632859911
DeepCCS[M+H]+230.54430932474
DeepCCS[M-H]-228.23430932474
DeepCCS[M-2H]-261.47530932474
DeepCCS[M+Na]+236.40330932474

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Revefenacin,1TMS,isomer #1CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C14994.9Semi standard non polar33892256
Revefenacin,1TMS,isomer #1CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C13864.8Standard non polar33892256
Revefenacin,1TMS,isomer #1CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C16591.2Standard polar33892256
Revefenacin,1TMS,isomer #2CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C14907.4Semi standard non polar33892256
Revefenacin,1TMS,isomer #2CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C13619.1Standard non polar33892256
Revefenacin,1TMS,isomer #2CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C16961.3Standard polar33892256
Revefenacin,2TMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C14789.1Semi standard non polar33892256
Revefenacin,2TMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C13798.1Standard non polar33892256
Revefenacin,2TMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C)CC2)C=C16191.1Standard polar33892256
Revefenacin,2TMS,isomer #2CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C15017.5Semi standard non polar33892256
Revefenacin,2TMS,isomer #2CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C14024.1Standard non polar33892256
Revefenacin,2TMS,isomer #2CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C16364.9Standard polar33892256
Revefenacin,3TMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C14863.7Semi standard non polar33892256
Revefenacin,3TMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C13989.6Standard non polar33892256
Revefenacin,3TMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)CC2)C=C15913.0Standard polar33892256
Revefenacin,1TBDMS,isomer #1CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C15156.9Semi standard non polar33892256
Revefenacin,1TBDMS,isomer #1CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C14135.9Standard non polar33892256
Revefenacin,1TBDMS,isomer #1CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C16600.5Standard polar33892256
Revefenacin,1TBDMS,isomer #2CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C15119.5Semi standard non polar33892256
Revefenacin,1TBDMS,isomer #2CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C13912.0Standard non polar33892256
Revefenacin,1TBDMS,isomer #2CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(N)=O)CC2)C=C16939.6Standard polar33892256
Revefenacin,2TBDMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C15151.4Semi standard non polar33892256
Revefenacin,2TBDMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C14367.4Standard non polar33892256
Revefenacin,2TBDMS,isomer #1CN(CCN1CCC(OC(=O)N(C2=CC=CC=C2C2=CC=CC=C2)[Si](C)(C)C(C)(C)C)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N[Si](C)(C)C(C)(C)C)CC2)C=C16186.7Standard polar33892256
Revefenacin,2TBDMS,isomer #2CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC2)C=C15331.5Semi standard non polar33892256
Revefenacin,2TBDMS,isomer #2CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC2)C=C14579.9Standard non polar33892256
Revefenacin,2TBDMS,isomer #2CN(CCN1CCC(OC(=O)NC2=CC=CC=C2C2=CC=CC=C2)CC1)C(=O)C1=CC=C(CN2CCC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC2)C=C16291.7Standard polar33892256
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 10V, Positive-QTOFsplash10-0f6t-0645790000-641f1a52fd27fb341be62017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 20V, Positive-QTOFsplash10-014i-0943210000-9d5dc2932532f3ba20e32017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 40V, Positive-QTOFsplash10-014j-0940000000-349d9975fec5d95a05ad2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 10V, Negative-QTOFsplash10-0007-0910330000-43671787dda8481e523b2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 20V, Negative-QTOFsplash10-00kf-0911110000-8bc4af1cb36d004a80a62017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 40V, Negative-QTOFsplash10-00kf-4910000000-0f2db02386b403b456252017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 10V, Positive-QTOFsplash10-0002-0001090000-1072b90b380da46d9c4d2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 20V, Positive-QTOFsplash10-0002-0234290000-bef4d8ec5b012c3f12192021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 40V, Positive-QTOFsplash10-0002-5945020000-07843a1dc4454660669c2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 10V, Negative-QTOFsplash10-0002-0041190000-7d0207050c49ebd7f3c12021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 20V, Negative-QTOFsplash10-0hfw-1653290000-2df29617f8d75130cd812021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Revefenacin 40V, Negative-QTOFsplash10-0006-5920040000-d6323f2b7aea2e741eaf2021-10-11Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11855
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9928376
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11753673
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available